EFFECTS OF HYPERTHERMIA AND TUMOUR NECROSIS FACTOR ON INFLAMMATORY CYTOKINE SECRETION AND PROCOAGULANT ACTIVITY IN ENDOTHELIAL CELLS

This publication has 19 references indexed in Scilit:

• Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.
  Journal of Clinical Oncology, 1998
• Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics
  Cancer, 1997
• Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
  Annals of Surgical Oncology, 1997
• Isolated limb perfusion for malignant melanoma
  Seminars in Surgical Oncology, 1996
• TNF-α and endotoxin serum levels in cancer patients undergoing intraperitoneal hyperthermic perfusion
  International Journal of Hyperthermia, 1996
• Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)
  International Journal of Cancer, 1994
• Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.
  The Journal of Experimental Medicine, 1988
• Vascular Endothelium as the Vulnerable Element in Tumours
  Acta Radiologica: Oncology, 1984
• Cytotoxic Effects of Hyperthermia and Adriamycin on Chinese Hamster Cells2
  JNCI Journal of the National Cancer Institute, 1976
• An endotoxin-induced serum factor that causes necrosis of tumors.
  Proceedings of the National Academy of Sciences, 1975